Welcome

HOPE Research Institute is an independent, multi-specialty, research organization dedicated to conducting clinical research trials in partnership with Valley physicians and their patients.

With NIH certified investigators and ACRP certified study coordinators, HOPE Research Institute can conduct inpatient and outpatient clinical trials across the Phoenix area.

HOPE Research Institute, LLC, conducts clinical research projects for the pharmaceutical industry in the Valley of the Sun, Phoenix, Arizona. Under the careful supervision of trained, experienced physicians, Valley residents can participate in studies of investigational products. HOPE's research facility is conveniently located in North Phoenix on Union Hills Drive near the intersection of freeways 51 and 101. Participants are placed into studies in a variety of therapeutic areas, depending on their eligibility. HOPE's therapeutic ares include: Family / Internal Medicine, Gastroenterology, Neurology / Sleep Medicine, Ophthalmology, Orthopedics / Orthopedic Surgery, Pain Management, Podiatry, Urology, or Women's Health. Study participation can be a positive experience for both the physician and the patient that may provide opportunities for learning, healthcare, and the betterment of our society.

Health and Clinical Research - Latest Headlines

Food and Drug Administration--Press Releases

FDA expands alert to health care providers about lack of sterility assurance of all sterile drug products from NuVision Pharmacy - 18 May 2013The U.S. Food and Drug Administration is alerting health care providers of concerns about a lack of sterility assurance of all sterile drug products made and distributed by NuVision Pharmacy of Dallas, Texas. The FDA recommends that these products should not be administered to patients.
FDA seeks preliminary injunction against New York fish manufacturer - 17 May 2013The U.S. Department of Justice, on behalf of the U.S. Food and Drug Administration (FDA), is seeking a preliminary injunction in the U.S. District Court for the Eastern District of New York against New York City Fish, Inc., and several key employees for manufacturing and distributing ready-to-eat fish products under insanitary conditions causing them to become adulterated.
FDA approves Simponi to treat ulcerative colitis - 15 May 2013The U.S. Food and Drug Administration today approved a new use for Simponi (golimumab) injection to treat adults with moderate to severe ulcerative colitis.
FDA approves new drug for advanced prostate cancer - 15 May 2013The U.S. Food and Drug Administration today approved Xofigo (radium Ra 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones but not to other organs. It is intended for men whose cancer has spread after receiving medical or surgical therapy to lower testosterone.
FDA approves Nymalize--first nimodipine oral solution for use in certain brain hemorrhage patients - 14 May 2013On May 10, the U.S. Food and Drug Administration approved Nymalize, a new nimodipine oral solution, to treat patients experiencing symptoms resulting from ruptured blood vessels in the brain (subarachnoid hemorrhage). Nimodipine previously was available only as a liquid-filled gel capsule.

NIH News Releases

Taming suspect gene reverses schizophrenia-like abnormalities in mice - 22 May 2013Scientists have reversed behavioral and brain abnormalities in adult mice that resemble some features of schizophrenia by restoring normal expression to a suspect gene that is over-expressed in humans with the illness. Targeting expression of the gene Neuregulin1, which makes a protein important for brain development, may hold promise for treating at least some patients with the brain disorder, say researchers funded by the National Institutes of Health.
NIH researchers conduct first genomic survey of human skin fungal diversity - 22 May 2013While humans have harnessed the power of yeast to ferment bread and beer, the function of yeast or other types of fungi that live in and on the human body is not well understood. In the first study of human fungal skin diversity, National Institutes of Health researchers sequenced the DNA of fungi at skin sites of healthy adults to define the normal populations across the skin and to provide a framework for investigating fungal skin conditions.
NIH funds studies to improve type 2 and prediabetes treatment - 22 May 2013The National Institutes of Health is looking for volunteers to take part in one of three clinical trials to improve and preserve the production of insulin in people with prediabetes or recently diagnosed type 2 diabetes. The project is called the Restoring Insulin Secretion study (RISE).
NINR welcomes five new members to the National Advisory Council for Nursing Research - 21 May 2013The National Institute of Nursing Research (NINR) announced the appointment of five new members to the National Advisory Council for Nursing Research (NACNR), the institute's principal advisory board. Members of the council are drawn from the scientific and lay communities, embodying a diverse perspective from the fields of nursing, public and health policy, law, and economics. NINR, a component of the National Institutes of Health, is the primary federal agency for the support of nursing research

World Health Organization News

World Health Assembly opens to discuss major health issues - 20 May 201320 May 2013 -- WHO's Health Assembly, the world's largest health policy-making body, opened its Sixty-sixth Session today in Geneva with around 3000 participants from around the world.
Yellow fever vaccination booster not needed - 16 May 201317 May 2013 -- The yellow fever ?booster? vaccination given ten years after the initial vaccination is not necessary, according to WHO.
WHO statistics show narrowing health gap between countries with best and worst health status - 14 May 201315 May 2013 -- The world has made dramatic progress in improving health in the poorest countries and narrowing the gaps between countries with the best and worst health status in the past two decades, according to the World Health Statistics 2013.
2.4 billion people will lack improved sanitation in 2015 - 13 May 201313 May 2013 ? Some 2.4 billion people ? one-third of the world?s population ? will remain without access to improved sanitation in 2015, according to a joint WHO/UNICEF report issued today.